Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

2241 - 2250 of 51970 results found

Prozone masks elevated SARS-CoV-2 antibody level measurements

Date
Thursday, March 28, 2024 - 4:00 AM
Description
We report a prozone effect in measurement of SARS-CoV-2 spike protein antibody levels from an antibody surveillance program. Briefly, the prozone effect occurs in immunoassays when excessively high antibody concentration disrupts the immune complex

Tuberculosis - United States, 2023

Date
Thursday, March 28, 2024 - 4:00 AM
Description
After 27 years of declining U.S. tuberculosis (TB) case counts, the number of TB cases declined considerably in 2020, coinciding with the COVID-19 pandemic. For this analysis, TB case counts were obtained from the National TB Surveillance System. U.S

Ceftazidime/avibactam serum concentration in patients on ECMO

Date
Thursday, March 28, 2024 - 4:00 AM
Description
CONCLUSIONS: In ECMO patients receiving ceftazidime/avibactam, ceftazidime and avibactam serum levels are above EUCAST breakpoints in most cases, justifying the use of normal dosing in ECMO patients. Increased renal clearance may lead to ceftazidime

Individual- and Community-Level Predictors of Hospital-at-Home Outcomes

Date
Thursday, March 28, 2024 - 4:00 AM
Description
Advanced Care at Home is a Mayo Clinic hospital-at-home (HaH) program that provides hospital-level care for patients. The study examines patient- and community-level factors that influence health outcomes. The authors performed a retrospective study

Indoor Inactivation of SARS-CoV-2 Virus by Liquid Hyperoxygen

Date
Wednesday, March 27, 2024 - 4:00 AM
Description
The possible future emergence of new SARS-CoV-2 virus variants pushes the development of new chemoprophylaxis protocols complementary to the unspecific and specific immune-prophylaxis measures currently used. The SARS-CoV-2 virus is particularly